Non-invasive Blood Pressure Monitors Market is Subject to Grow At A Higher CAGR 8.8% by 2027 | Coherent Market Insights
Non-invasive Blood Pressure Monitors Market is Subject to Grow At A Higher CAGR 8.8% by 2027 | Coherent Market Insights
Published by Coherent Market Insights
Posted on September 21, 2021
Blood pressure monitors are used to measure the level of blood pressure of patients and are mostly found across the operating room, intensive care units, surgical recovery rooms, emergency departments and other critical care areas for frequent or continuous measurement of blood pressure. Blood pressure measurement is integral to intensive care units to check vital signs and is also used to screen for hypertension, to estimate cardiovascular risk and manage, diagnose and treat acute and chronic medical conditions. Non-invasive blood pressure uses a double finger cuff that easy to place on hand. Sphygmomanometer and auscultation are the most popular type of non-invasive blood pressure monitor. They are simpler and quicker than the invasive measurements and also requires less expertise in fitting and have no virtual complications, these factors are expected to favor the market growth. On the other side, a non-invasive blood pressure monitor is somewhat less accurate and also shows little systematic differences in numerical results are the major expected to hamper the market growth.
The rise in the number of cardiovascular diseases are projected to fuel the growth of non-invasive blood pressure monitors market
The risk of cardiovascular disease increase if blood pressure is above 115/75 mmHg. In the UK, blood pressure is classified into 3 groups; low (90/60 or lower), normal (between 90/60 and 139/89), and high (140/90 or higher). Blood pressure fluctuates from minute to minute and shows a circadian rhythm within 24 hours. In the U.S. leading cause of death are heart disease and stroke due to high blood pressure. According to the Centers for Disease Control and Prevention, in the year 2016, about 75 million adults of the U.S. had high blood pressure which is expected to support the growth of non-invasive blood pressure monitors market. Growing cases of low blood pressure are also expected to favor the market of non-invasive blood pressure monitors as it is associated with serious symptoms such as dizziness, nausea, fatigue, cold, pale skin or blurred vision.
Regional growth engines for the non-invasive blood pressure monitors market
Based on regional segmentation, the global colostomy bags market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The emerging economies such as India, China, Brazil, and South Africa are expected to be major target geographies for market players. North America is expected to show growth in the market owing to continuous growth in the aging population and the rate of medical conditions related to high blood pressure. According to the Population Reference Bureau, the number of people of the U.S. aged over 65 years is projected to more than double from 46 million in 2016 to 98 million by 2060. Furthermore, a decline in price to make noninvasive blood pressure monitors cost-effective for hospitals expected to favor the noninvasive blood pressure monitors market in the Asia Pacific region.
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Key players dominating in the non-invasive blood pressure monitors market
Non-invasive blood pressure monitor providers in the market are focusing on offering a broad and cost-effective range of non-invasive blood pressure monitors in the market by using advanced technology and innovation in products, which in turn is increasing competitive rivalry. In May 2017, Deltex Medical was granted a patent for combined blood flow and blood pressure monitor by a non-invasive method which will favor the growth of the market. Other key players operating in the market are GE healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd, Mortara Instrument, Schiller Americans Inc, American Diagnostic Corporation and Welch Allyn.
Blood pressure monitors are used to measure the level of blood pressure of patients and are mostly found across the operating room, intensive care units, surgical recovery rooms, emergency departments and other critical care areas for frequent or continuous measurement of blood pressure. Blood pressure measurement is integral to intensive care units to check vital signs and is also used to screen for hypertension, to estimate cardiovascular risk and manage, diagnose and treat acute and chronic medical conditions. Non-invasive blood pressure uses a double finger cuff that easy to place on hand. Sphygmomanometer and auscultation are the most popular type of non-invasive blood pressure monitor. They are simpler and quicker than the invasive measurements and also requires less expertise in fitting and have no virtual complications, these factors are expected to favor the market growth. On the other side, a non-invasive blood pressure monitor is somewhat less accurate and also shows little systematic differences in numerical results are the major expected to hamper the market growth.
The rise in the number of cardiovascular diseases are projected to fuel the growth of non-invasive blood pressure monitors market
The risk of cardiovascular disease increase if blood pressure is above 115/75 mmHg. In the UK, blood pressure is classified into 3 groups; low (90/60 or lower), normal (between 90/60 and 139/89), and high (140/90 or higher). Blood pressure fluctuates from minute to minute and shows a circadian rhythm within 24 hours. In the U.S. leading cause of death are heart disease and stroke due to high blood pressure. According to the Centers for Disease Control and Prevention, in the year 2016, about 75 million adults of the U.S. had high blood pressure which is expected to support the growth of non-invasive blood pressure monitors market. Growing cases of low blood pressure are also expected to favor the market of non-invasive blood pressure monitors as it is associated with serious symptoms such as dizziness, nausea, fatigue, cold, pale skin or blurred vision.
Regional growth engines for the non-invasive blood pressure monitors market
Based on regional segmentation, the global colostomy bags market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The emerging economies such as India, China, Brazil, and South Africa are expected to be major target geographies for market players. North America is expected to show growth in the market owing to continuous growth in the aging population and the rate of medical conditions related to high blood pressure. According to the Population Reference Bureau, the number of people of the U.S. aged over 65 years is projected to more than double from 46 million in 2016 to 98 million by 2060. Furthermore, a decline in price to make noninvasive blood pressure monitors cost-effective for hospitals expected to favor the noninvasive blood pressure monitors market in the Asia Pacific region.
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Key players dominating in the non-invasive blood pressure monitors market
Non-invasive blood pressure monitor providers in the market are focusing on offering a broad and cost-effective range of non-invasive blood pressure monitors in the market by using advanced technology and innovation in products, which in turn is increasing competitive rivalry. In May 2017, Deltex Medical was granted a patent for combined blood flow and blood pressure monitor by a non-invasive method which will favor the growth of the market. Other key players operating in the market are GE healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd, Mortara Instrument, Schiller Americans Inc, American Diagnostic Corporation and Welch Allyn.